HomeQuestion

Would you consider using Breast Cancer Index to make decisions about extending AI therapy in patients who completed 5 years of AI, given recent data presented at SABCS 2022 about validation of BCI in IDEAL trial?

2 Answers

Mednet Member

Medical Oncology · University of Vermont College of Medicine

Use routinely.

Mednet Member

Medical Oncology · Illinois Cancer Care

I use it routinely in the 5th year of AI for LN negative cases. I heard there's difficulty in getting it covered for LN positive cases. Will review the above data. Thanks!